NFG
SRNE

Next Financial Group’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Next Financial Group’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$5K Hold
1,028
– – ﹤0.01% 2449
2021
Q3 		$8K Buy
1,028
+928
+928% +$7.87K ﹤0.01% 2121
2021
Q2 		$1K Hold
100
– – ﹤0.01% 2599
2021
Q1 		$1K Buy
+100
New +$1.06K ﹤0.01% 2499

Other funds holding SRNE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Next Financial Group's SRNE Position: Q4 2021 in Review

Next Financial Group held its Sorrento Therapeutics, Inc. (SRNE) position steady in Q4 2021 at 1,028 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #2449.

Next Financial Group first reported a position in SRNE in Q1 2021 and has held it in 4 quarters since. The position peaked at $8K in Q3 2021. 234 funds tracked by Wall St. Rank hold SRNE as of Q4 2021.

  • Next Financial Group held 1,028 shares of Sorrento Therapeutics, Inc. worth $5K as of Q4 2021.
  • Next Financial Group left its Sorrento Therapeutics, Inc. share count unchanged in Q4 2021.
  • Sorrento Therapeutics, Inc. made up ﹤0.01% of Next Financial Group's portfolio in Q4 2021, its #2449 holding.
  • Next Financial Group first reported a position in Sorrento Therapeutics, Inc. in Q1 2021 and has held it in 4 quarters since.
  • Next Financial Group's Sorrento Therapeutics, Inc. position peaked at $8K in Q3 2021.
  • 234 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q4 2021.

Based on Next Financial Group's 13F filing for Q4 2021, filed 15 Feb 2022.